Abstract:Background: Basal ganglia and thalamic arteriovenous malformations (AVMs) represent a special subset of malformations. Due to the involvement of vital brain structures and the specifically fine and delicate angioarchitecture of these lesions, it presents unique therapeutic challenges and technical difficulties that require thorough treatment planning, individualized treatment strategies, and advanced techniques for good clinical outcome. Method: In this study, we presented a series of ruptured basal ganglia and thalamic AVMs embolized via a transarterial, transvenous or combined approach. Herein, we summarized our treatment experience and clinical outcomes to further evaluate the effectiveness and safety of endovascular embolization for these AVMs as well as the indications, therapy strategies, and techniques of embolization procedures. Results: Twelve patients with basal ganglia and thalamus AVMs were included in the study. Their average age was 23.83 ± 16.51 years (range, 4–57 years) with a female predominance of 67% at presentation. The AVMs were located in the thalamus in 3 (25%) patients, in the basal ganglia in 3 (25%) patients, and in both sites of the brain in 6 (50%) patients. There were 5 AVMs located on the left side and 7 on the right. The mean nidus diameter was 3.32 ± 1.43 cm (range 1.3–6.1 cm). According to the Spetzler-Martin grading classification, 4 (33.3%) brain AVMs were Grade III, 7 (58.3%) were Grade IV, and 1 (8.3%) was Grade V. All of them presented with bleeding at admission: four of these patients presented with an intracerebral hemorrhage (ICH), 8 ICH in combination with intraventricular hemorrhage (IVH), and no patient with subarachnoid hemorrhage (SAH). Among these patients treated with endovascular embolization, 7 patients were treated by the transarterial approach, 4 patients transvenous approach, and 1 patient underwent the combined approach. A single embolization procedure was performed in 6 patients (50%) and the other 6 cases (50%) were treated in a staged manner with up to three procedures. Procedure-related complications occurred only in two patient (16.7%). Complete AVM obliteration was obtained in 7 patients (58.3%), and partial obliteration was in 4 patients (33.3%). Overall, good or excellent outcomes were obtained in 7 patients (58.3%), and poor functional outcome was observed in 5 patients (41.7%) at the last follow-up. All survived patients achieved anatomic stabilization and there was no postoperative bleeding or recurrence in the follow-up. Conclusion: The management of the basal ganglia and thalamic AVMs is a great challenge, which needs multimodal individualized treatment to improve the chances of radiographic cure and good outcomes. Endovascular therapy is safe and effective in the treatment of cerebral AVMs particularly for deep-seated AVMs such as the basal ganglia and thalamus. Our results demonstrate a high rate of anatomic obliteration with an acceptable rate of complications in the endovascular treatment of these vasculopathies via a transarterial approach or a transvenous approach.

Application of Epinephrine Mixed with Local Anaesthetics in Injection Sclerotherapy of Early-Stage Arteriovenous Malformation.

Treatment of high grade cerebral anteriovenous malformations with Onyx embolic agent

Microsurgical Excision Combined with Preoperational Endovascular Embolization in Treatment of Cerebral Arteriovenous Malformation

Effect of radiofrequency ablation combined with DSA-guided percutaneous ethanol sclerotherapy for refractory arteriovenous malformations in oral and maxillofacial region

[Efficacy of Suture Ligation Combined with Super-Wet Tumescent Techniques in Resection of Peripheral Arteriovenous Malformations of Head and Neck].

Clinical Effect of Radiofrequency Ablation Combined with Digital Subtraction Angiography-Guided Percutaneous Ethanol Injection Sclerotherapy in the Management of High-Return Flow Venous Malformation

Case report: Endovascular treatment of two scalp arteriovenous malformation cases via direct percutaneous catheterization: A case series

Surgical Removal of Intracranial Arteriovenous Malformation Immediately after Embolization According to the Results of LYS Grading Scale

Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins

Results of Endovascular-First Approach for Treatment of Scalp Arteriovenous Malformations and the Effect of Simplified Angiographic Classification in Therapeutic Decision-Making and Outcomes

Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy

Targeting the microenvironment in the treatment of arteriovenous malformations

Percutaneous Puncture Embolization with Absolute Ethanol under Digital Subtraction Angiography for Arteriovenous Malformations in Oral and Maxillofacial Region

Retrospective clinical study on the efficacy and complications of interventional embolization in the treatment of scalp arteriovenous fistula

Adding a sclerosant to endoscopic epinephrine injection in actively bleeding ulcers: a randomized trial

Applicaltional Study of Absolute Ethanol Injection and Pingyangmycin Instrallation with Dynamic Intranidus Infusion to Treat Venous Malformation in Maxillofacial Region

Single-Stage Combined Embolization and Resection for Spetzler-Martin Grade III/IV/V Arteriovenous Malformations: A Single-Center Experience and Literature Review

Quantitative Assessment of Hemodynamics Associated With Embolization Degree in Brain Arteriovenous Malformations

Absolute Ethanol Embolization of Lip Arteriovenous Malformations: Observational Results from 10 Years of Experience

Application of embolization for arteriovenous malformations of the soft tissue in oral and maxillofacial region

Endovascular embolization for basal ganglia and thalamic arteriovenous malformations